Sarcopenia is linked to higher levels of B-type natriuretic peptide and its N-terminal fragment in heart failure: a systematic review and meta-analysis
Open Access
- 8 March 2024
- journal article
- research article
- Published by Springer Nature in European Geriatric Medicine
- Vol. 15 (4) , 893-901
Abstract
Aims: Sarcopenia is linked to impaired physical function and exercise tolerance. The aim of this systematic review and meta-analysis was to examine the association of sarcopenia and low appendicular skeletal muscle (ASM) with biomarkers of cardiac function, B-type natriuretic peptide (BNP) and its N-terminal fragment (NT-proBNP), in patients with heart failure (HF). Methods and results: From inception until May 2023, a systematic literature search of observational studies was undertaken utilizing the PubMed, Web of Science, Scopus, and Cochrane Library databases. A meta-analysis employing a random-effects model was used to compute the pooled effects (CRD42023418465). Overall, 16 studies were included in this systematic review and meta-analysis. Our main analysis showed that sarcopenia in HF was linked to significantly higher levels of BNP (MD: 87.76, 95% CI 20.74–154.78, I2 = 61%, P = 0.01) and NT-proBNP (MD: 947.45, 95% CI 98.97–1795.93, I2 = 35%, P = 0.03). Similarly, low ASM was associated with significantly higher levels of BNP (MD: 118.95, 95% CI 46.91–191.00, I2 = 93%, P < 0.01) and NT-proBNP (MD: 672.01, 95% CI 383.72–960.30, I2 = 2%, P < 0.01). The quality of the included cohort studies was considered moderate, using the binary AXIS checklist and the Cochrane Tool to Assess the Risk of Bias in Cohort Studies. Conclusions: In patients with HF, sarcopenia and reduced ASM are associated with considerably higher plasma levels of BNP and NT-proBNP. Future research is required to investigate whether sarcopenia may express dysregulated biomarkers of cardiac function. GraphicalKeywords
This publication has 68 references indexed in Scilit:
- Prognostic Impact of Upper and Lower Extremity Muscle Mass in Heart FailureESC Heart Failure, 2022
- Anthropometric Parameters-Derived Estimation of Muscle Mass Predicts All-Cause Mortality in Heart Failure PatientsESC Heart Failure, 2022
- Sarcopenia in Heart Failure: A Systematic Review and Meta-AnalysisESC Heart Failure, 2021
- Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipinJournal of Cachexia, Sarcopenia and Muscle, 2020
- Muscle wasting as an independent predictor of survival in patients with chronic heart failureJournal of Cachexia, Sarcopenia and Muscle, 2020
- Discriminating Sarcopenia in Overweight/Obese Male Patients with Heart Failure: The Influence of Body Mass IndexESC Heart Failure, 2019
- Cochrane Handbook for Systematic Reviews of Interventions2019
- Weight loss in heart failure is associated with increased mortality only in non‐obese patients without diabetesJournal of Cachexia, Sarcopenia and Muscle, 2019
- Bioelectrical impedance analysis of body composition and survival in patients with heart failureClinical Cardiology, 2018
- Muscle wasting in young patients with dilated cardiomyopathyJournal of Cachexia, Sarcopenia and Muscle, 2017